Armistice Capital, LLC Kura Oncology, Inc. Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 5,800,000 shares of KURA stock, worth $48 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
5,800,000
Previous 2,658,000
118.21%
Holding current value
$48 Million
Previous $51.9 Million
2.73%
% of portfolio
0.71%
Previous 0.86%
Shares
9 transactions
Others Institutions Holding KURA
# of Institutions
192Shares Held
77.5MCall Options Held
103KPut Options Held
106K-
Black Rock Inc. New York, NY6.97MShares$57.7 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$42 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.82MShares$39.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.45MShares$36.9 Million0.63% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.56MShares$29.5 Million1.45% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $554M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...